S. Ghate

发表

Hemorrhagic and Thrombotic Events Associated with Generic Substitution of Warfarin in Patients with Atrial Fibrillation: A Retrospective Analysis

E. S. Fox, Xiangyang Ye, D. Brixner, 2011, The Annals of pharmacotherapy.

Cost Effectiveness Analysis Of Mri Guided Ablation Based On The Decaaf Trial

N. Marrouche, J. Biskupiak, M. Singhal, 2014 .

Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study.

R. Ionescu-Ittu, M. Duh, F. Laliberté, 2019, Future oncology.

Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and Japan

Jeri Kim, A. Leith, S. Ghate, 2022, Advances in Therapy.

Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspective

T. Delea, M. Gerbasi, P. Gunda, 2019, Journal of medical economics.

A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the US

V. Villalobos, S. Byfield, O. Adejoro, 2017, Clinical Sarcoma Research.

Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and Japan

Jeri Kim, A. Leith, S. Ghate, 2022, BMC Urology.

Systematic Literature Review of the Epidemiology of Advanced Prostate Cancer and Associated HRR Gene Alterations.

A. Gayle, I. Shui, N. Shore, 2020, The Journal of urology.

Fat Modulates the Relationship between Sarcopenia and Physical Function in Nonobese Older Adults

R. Marcus, D. Brixner, P. LaStayo, 2012, Current gerontology and geriatrics research.

Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)

N. Agarwal, K. Abrams, N. Hawkins, 2021, Targeted Oncology.

Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA

N. Vogelzang, S. Pal, J. Signorovitch, 2017, International journal of urology : official journal of the Japanese Urological Association.

The Additional Costs per Month of Progression-Free Survival and Overall Survival: An Economic Model Comparing Everolimus with Cabozantinib, Nivolumab, and Axitinib for Second-Line Treatment of Metastatic Renal Cell Carcinoma

E. Swallow, A. Messali, E. Duchesneau, 2018, Journal of managed care & specialty pharmacy.

Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors

R. Ionescu-Ittu, N. Shore, M. Duh, 2021, Advances in Therapy.

Predictors of metabolic parameter monitoring in adolescents on antipsychotics in a primary care setting.

M. Hashibe, D. Brixner, Q. Said, 2012, Mental health in family medicine.

Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan.

Jeri Kim, A. Leith, S. Ghate, 2022, Future oncology.

All-Cause and Bleeding-Related Health Care Costs in Warfarin-Treated Patients with Atrial Fibrillation

Joseph Biskupiak, Xiangyang Ye, D. Brixner, 2011, Journal of managed care pharmacy : JMCP.

Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study.

J. Luke, B. Feinberg, J. Kish, 2019, Future oncology.

Validity of Self-reported Smoking Status among Participants in a Lung Cancer Screening Trial

Christopher N. Barnes, A. Lajoie, M. Andrykowski, 2006, Cancer Epidemiology Biomarkers & Prevention.

Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma

A. Manceur, R. Ionescu-Ittu, M. Duh, 2018, Melanoma research.

Cost Implications of Formulary Decisions on Oral Anticoagulants in Nonvalvular Atrial Fibrillation

D. Brixner, J. Biskupiak, T. Jiao, 2013, Journal of managed care pharmacy : JMCP.

Healthcare utilization and costs for patients initiating Dabigatran or Warfarin

S. Annavarapu, P. Gandhi, S. Sander, 2017, Health and Quality of Life Outcomes.

Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive

R. Ionescu-Ittu, M. Duh, F. Laliberté, 2018, Melanoma research.

Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly.

Zhiyi Li, Jackson Tang, S. Ghate, 2018, American health & drug benefits.

Real‐World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER–Medicare Database Analysis

N. Agarwal, N. Vogelzang, S. Pal, 2017, Clinical genitourinary cancer.

Predictors of Long‐Term Response With Pazopanib in Patients With Advanced Renal‐Cell Carcinoma

N. Vogelzang, Q. Ahmad, S. Ghate, 2018, Clinical genitourinary cancer.

Depression May Mediate the Relationship between Sense of Coherence and Quality of Life in Lung Cancer Patients

B. Stetson, P. Salmon, I. Weissbecker, 2011, Journal of health psychology.

Results of a Qualitative Study to Develop a Patient Reported Outcome Measure for Patients with 4 Subtypes of Soft Tissue Sarcoma

A. Rentz, A. Skalicky, S. Ghate, 2017, Sarcoma.

Development of a practical screening tool to predict low muscle mass using NHANES 1999–2004

S. Sen, R. Marcus, D. Brixner, 2013, Journal of cachexia, sarcopenia and muscle.

Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis

N. Agarwal, N. Vogelzang, S. Pal, 2017, Advances in Therapy.

Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study.

R. Ionescu-Ittu, Jeri Kim, N. Shore, 2021, Clinical genitourinary cancer.

Cost and Comorbidities Associated with Opioid Abuse in Managed Care and Medicaid Patients in the United States: A Comparison of Two Recently Published Studies

C. McAdam-Marx, S. Haroutiunian, S. Ghate, 2010, Journal of pain & palliative care pharmacotherapy.

Patient preferences for treatment of metastatic melanoma.

C. Mansfield, S. Ghate, B. Ndife, 2019, Future Oncology.

Association between second-generation antipsychotics and changes in body mass index in adolescents.

M. Hashibe, D. Brixner, Q. Said, 2013, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Association Between Cardiometabolic Risk Factors and Body Mass Index Based on Diagnosis and Treatment Codes in an Electronic Medical Record Database

C. McAdam-Marx, D. Brixner, R. Ben-Joseph, 2008, Journal of managed care pharmacy : JMCP.

Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data

N. Agarwal, N. Vogelzang, S. Pal, 2018, Journal of Managed Care & Specialty Pharmacy.

Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy

R. Ionescu-Ittu, M. Duh, F. Laliberté, 2018, Current medical research and opinion.